论文信息 - Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease. - 字舞流文

Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease.

A. Sanyal | V. Luketic | M. Siddiqui | M. Idowu | S. Patel | M. Siddiqui | Jose A. Hernandez Roman | E. Zhang | Emily Lee | Steve S. Shen | M. Faridnia | Robert J Mintini | Sherry L Boyett

[1] A. Sanyal,et al. Small Dense Low‐Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients , 2019, Hepatology.

[2] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[3] Puneet Puri,et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4] Mats Fredrikson,et al. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.

[5] AndrewJ. S. Coats. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[6] Eun Mi Lee,et al. Statins do not decrease small, dense low-density lipoprotein. , 2010, Texas Heart Institute journal.